4
Changes in Ownership
Citius Pharmaceuticals, Inc. Filed Acc 0001213900-21-010318
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Holuka Eugene Myron Director | 2021-02-16 | Grant or award · Options to Purchase Common Stock | +25,000 | 25,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…